Emsam Transdermal Patch - 24 Hour 12Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

EMSAM: Transdermal patch - 24 Hour (12mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
EMSAM 12mg/24hr Patch

What is this Medicine?

SELEGILINE (se LE ji leen) is an monoamine oxidase inhibitor (MAOI). It is used to treat major depression.

CVS Pharmacy Patient Statistics for EMSAM: Transdermal patch - 24 Hour(12mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

EMSAM 12mg/24hr Transdermal Patch

NDC: 495020902
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Depression

Storage Information
Do not store outside of the sealed pouch
Store at controlled room temperature (between 68 and 77 degrees F)
EMSAM 12mg/24hr Transdermal Patch

Reported Side Effects for EMSAM 12mg/24hr Transdermal Patch

Thoughts Of Suicide Incidence:
0.1-1.0%*
Severity: SEVERE
Onset: DELAYED
Orgasm Dysfunction Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Mania Incidence:
0.4%*
Severity: MODERATE
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
0.7%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
0.7%*
Severity: MILD
Onset: DELAYED
Ejaculation Dysfunction Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
3.0-6.2%*
Severity: MODERATE
Onset: RAPID
Skin Rash Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Postural Low Blood Pressure Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
18.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for EMSAM 12mg/24hr Transdermal Patch

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Severe Lifestyle Interaction
Tyramine-containing foods and EMSAM 12mg/24hr Transdermal Patch(Selegiline Hydrochloride)
Tyramine-containing foods and Monoamine oxidase inhibitors(Selegiline Hydrochloride)
Avoid foods and beverages containing tyramine while taking this medicine. The following foods can cause sudden blood pressure increases and should also be avoided: aged cheese; yeast extract; protein extract; soy sauce; fava bean or broad bean pods; smoked meats; pickled meats; smoked poultry; pickled poultry; smoked fish (lox, smoked salmon); pickled fish (pickled herring); fermented sausage (bologna, pepperoni, salami, summer sausage); bananas; avocados; any over-ripe fruit. Selegiline products have specific guidelines. Dietary and beverage restrictions should continue for at least 2 weeks after stopping this medicine.
Severe Lifestyle Interaction
Alcohol and EMSAM 12mg/24hr Transdermal Patch(Selegiline Hydrochloride)
Alcohol and Monoamine oxidase inhibitors(Selegiline Hydrochloride)
Alcohol interactions with this medicine can be serious and may cause increased sedation, increased blood pressure ('hypertensive crisis') or other side effects. Ask your health care provider for a list of items to avoid. You must adhere to all dietary restrictions. Alcoholic beverages to avoid include beer; wine; sherry; hard liquor; or liqueurs. Dietary and beverage restrictions should continue for at least 2 weeks after stopping this medicine.
Severe Lifestyle Interaction
Caffeine-containing Foods/Beverages and EMSAM 12mg/24hr Transdermal Patch(Selegiline Hydrochloride)
Caffeine-containing Foods/Beverages and Monoamine oxidase inhibitors(Selegiline Hydrochloride)
Do not take this medicine with caffeine-containing dietary supplements, medicines, foods or beverages without talking to your health care provider. Food, medicine, and dietary interactions can be serious. Rapid heartbeats or serious increases in blood pressure, known as "hypertensive crisis", may occur. Try to avoid or limit the intake of all items containing caffeine such as tea, coffee, chocolate, and cola. Do not take nonprescription medicines that contain Caffeine, like "stay awake" or weight loss products, including herbal diet aids. Caffeine restrictions should continue for at least 1 to 2 weeks after stopping this medicine.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with EMSAM

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.